EDGAR Filing Documents for 0001193125-17-311346

Form 8-K - Current report:

SEC Accession No. 0001193125-17-311346

Filing Date

2017-10-17

Accepted

2017-10-17 07:36:33

Documents

Period of Report

2017-10-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d475830d8k.htm	8-K	23815
2	EX-99.1	d475830dex991.htm	EX-99.1	11527
3	EX-99.2	d475830dex992.htm	EX-99.2	8652
4	EX-99.3	d475830dex993.htm	EX-99.3	4252
5	GRAPHIC	g475830g1017101627565.jpg	GRAPHIC	2883
6	GRAPHIC	g475830g1017101846983.jpg	GRAPHIC	2883
	Complete submission text file	0001193125-17-311346.txt		57693

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400

Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)